Page 107 - JSOM Summer 2019
P. 107

An Ongoing Series



                                                  Measles Vaccination

                                      A Matter of Confidence and Commitment



                                    Richard Turner, on Behalf of the PLoS Medicine Editors*





                  rominent  among  the  anxieties  of  our  times  are  those   Vaccine Action Plan 2015–2020 recognizes the need for high
                  regarding health and disease. Not only are ageing pop-  and consistent levels of vaccine coverage yet acknowledges the
             Pulations expected to suffer an increased burden of non-  difficulties in meeting the challenges of achieving high and eq-
              communicable diseases in the future, but risks of and harms   uitable coverage, owing to the existing pronounced variations
              from existing and emerging infectious diseases could also   in national and regional coverage with measles vaccination.
              increase, owing to population growth, migration, climate
              change, and other factors. At the population level, it is clear   In the United States, despite the declared elimination of mea-
              that the hard-won gains in medicine and public health brought   sles in 2000, outbreaks have been well documented in recent
              about by vaccination, antimicrobial and other treatments, and   years—the outbreak in Southern California during December
              improved sanitation will need to be sustained, broadened, and   2014–February 2015 involved at least 125 cases.  Among
                                                                                                         3
              intensified to protect and provide for an increasing proportion   these cases, a substantial proportion were in people known
              of the human population. Global aspirations, including those   not to have been vaccinated, including infants who were too
              set out in the Sustainable Development Goals, are unambigu-  young to have been protected and individuals who had chosen
              ous in setting out an anticipated future trajectory of improved   not to receive measles vaccination (i.e., 49 people were unvac-
              health, well-being, and prosperity.                cinated among the 110 cases identified in California). More
                                                                 recently, an outbreak in Clark County, Washington State has
              Measles, a highly contagious viral infection, is in various re-  been widely reported in the past few weeks, and at the time
              spects the perfect example of a threat to health that respects   of writing there had been 65 confirmed measles cases in this
              neither aspirations nor boundaries between developed and   area.  In 2018, writing in  PLoS Medicine, Jacqueline Olive
                                                                    4
              developing countries. Complications of measles infection in-  and colleagues highlighted clusters of people claiming non-
              clude pneumonia (the most common cause of death in chil-  medical exemptions from measles vaccination in states where
              dren with measles), encephalitis, ear infections that can lead to   this is permitted by law.  The authors noted that “new foci
                                                                                    5
              permanent deafness, and diarrhea. Although a safe and very   of antivaccine activities are being established in major met-
              effective two-dose vaccination schedule has been available and   ropolitan areas, rendering select cities vulnerable for vaccina-
              widely deployed since the 1960s, the need for very high and   tion-preventable diseases.” It is difficult to imagine a future
              consistent vaccination coverage to elicit herd immunity means   scenario without repeated and serious measles outbreaks in
              that the disease burden and harms of measles remain substan-  the US and elsewhere, given the gaps in protection against the
              tial.  WHO  reports  that  globally,  in  an  apparent  uptrend  of   disease. A cautionary indication of the extent to which the
              cases occurring in 2017, measles led to an estimated 110,000   dangers of so-called “vaccine hesitancy” can escalate is in the
              deaths, most in children aged under 5 years.  Tragically, these   Philippines, where there are reported to have been thousands
                                                1
              deaths were unavoidable, given the estimated 20.8 million   of measles cases and at least 189 deaths since the beginning of
              children in low- and middle-income countries who had not   2019, mainly in children. 6
              received a single dose of measles vaccine through routine pro-
              grams in that year.                                The reasons for people not accepting vaccination against
                                                                 measles and other potentially fatal and readily preventable in-
              In  the  53 high-  and  middle-income  countries  that  make  up   fections are, unfortunately, all too well known. Fears about
              its European region, WHO has indicated that around 82,500   potential harms of the combined measles, mumps, and rubella
              cases of measles were reported in 2018, an alarmingly high   vaccination were raised by a discredited study published in
              number even among a population in excess of 900 million peo-  The Lancet in 1998 and are continuing to circulate. As Peter
              ple, and a greater than 3-fold increase since 2017.  There were   Hotez, dean of the National School of Tropical Medicine at
                                                    2
              72 reported deaths in children and adults. Here, the European   Baylor College of Medicine, Houston, Texas, commented to
              *Published: March 26, 2019; https://doi.org/10.1371/journal.pmed.1002770
              Copyright: © 2019 Turner, on behalf of the PLoS Medicine Editors. This is an open access article distributed under the terms of the Creative
              Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and
              source are credited.

                                                              105
   102   103   104   105   106   107   108   109   110   111   112